Omega Therapeutics (NASDAQ:OMGA – Get Free Report)‘s stock had its “outperform” rating reaffirmed by investment analysts at Wedbush in a research report issued on Monday, RTT News reports. They presently have a $12.00 price target on the stock. Wedbush’s price target would suggest a potential upside of 426.32% from the company’s current price. Several other […]